Enanta Pharmaceuticals Inc (ENTA) KPIs and segments
Close on Nov 13, 2026Market cap $320.09MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Enanta Pharmaceuticals's business
Enanta Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Enanta Pharmaceuticals's fiscal year ends September 30 — Q3 FY26 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q3 FY26 CQ2 2026 | Q2 FY26 CQ1 2026 | Q1 FY26 CQ4 2025 | Q4 FY25 CQ3 2025 | Q3 FY25 CQ2 2025 | Q1 FY25 CQ4 2024 | Q4 FY24 CQ3 2024 | Q3 FY24 CQ2 2024 | Q2 FY24 CQ1 2024 | Q1 FY24 CQ4 2023 | Q4 FY23 CQ3 2023 | Q3 FY23 CQ2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Royalty($M) | 14.4 | 17.2 | 18.6 | 15.1 | 18.3 | 17.0 | 14.6 | 18.0 | 17.1 | 18.0 | 18.9 | 18.9 | |
License($M) | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
1 metric has no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-12.
See a number that looks wrong?